Clinical Trials Directory

Trials / Unknown

UnknownNCT02848287

Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Children

Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Preschool-aged Children Undergoing Adenotonsillectomy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Ajou University School of Medicine · Academic / Other
Sex
All
Age
3 Years – 6 Years
Healthy volunteers
Not accepted

Summary

Emergence agitation (EA) is highly prevalent in children after surgery. Risk factors for EA are Eye, nose and throat (ENT) surgery, preoperative anxiety, postoperative pain. There are several preventive strategies but none of them completely prevent EA. Topical application of ropivacaine can reduce post-tonsillectomy pain. Therefore, it might reduce the incidence of postoperative EA.

Conditions

Interventions

TypeNameDescription
DRUGnormal saline1\*2 gauze is soaked with 5 cc of 0.9 % normal saline, applied in tonsillar fossae for 3 min, then removed.
DRUGropivacaine1\*2 gauze is soaked with 5 cc of 0.75% ropivacaine, applied in tonsillar fossae for 3 min, then removed.

Timeline

Start date
2016-08-01
Primary completion
2017-07-01
Completion
2017-08-01
First posted
2016-07-28
Last updated
2016-07-28

Source: ClinicalTrials.gov record NCT02848287. Inclusion in this directory is not an endorsement.